‘Another period of long-term growth’: HCA’s financial performance over the past 5 years 

HCA CEO Sam Hazen said on the company’s fourth-quarter earnings report that the first half of the decade “proved to be another period of long-term growth for the company and resulted in operational improvements across key performance indicators and greater value for our patients, employees and shareholders.”

Advertisement

Here is a look at how the Nashville, Tenn.-based for-profit health system performed financially in the first half of the decade:

2020

  • Revenue: $51.5 billion
  • Operating expenses: $46.1 billion
  • Operating income: $5.4 billion
  • Operating margin: 10.5%
  • Net income: $3.8 billion

2021

  • Revenue: $58.8 billion
  • Operating expenses: $48.9 billion
  • Operating income: $9.8 billion
  • Operating margin: 16.7%
  • Net income: $7 billion

2022

  • Revenue: $60.2 billion
  • Operating expenses: $51.7 billion
  • Operating income: $8.6 billion
  • Operating margin: 14.2%
  • Net income: $5.6 billion

2023

  • Revenue: $65 billion
  • Operating expenses: $57.3 billion
  • Operating income: $7.7 billion
  • Operating margin: 11.9%
  • Net income: $5.2 billion

2024

  • Revenue: $70.6 billion
  • Operating expenses: $62.1 billion
  • Operating income: $8.5 billion
  • Operating margin: 12.1%
  • Net income: $5.8 billion

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.